Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of ATP2B4 mRNA | affects expression | 16483693
|
D001151 |
Arsenic |
Arsenic affects the expression of ATP2B4 mRNA | affects expression | 18414638
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of ATP2B4 mRNA | decreases expression | 20064835
|
C006780 |
bisphenol A |
bisphenol A inhibits the reaction [Triiodothyronine results in increased expression of ATP2B4 mRNA] | decreases reaction|increases expression | 19228888
|
D002118 |
Calcium |
ATP2B4 protein results in increased export of Calcium | increases export | 16452157
|
D002118 |
Calcium |
caloxin 1b1 inhibits the reaction [ATP2B4 protein results in increased export of Calcium] | decreases reaction|increases export | 16452157
|
C510327 |
caloxin 1b1 |
caloxin 1b1 inhibits the reaction [ATP2B4 protein results in increased export of Calcium] | decreases reaction|increases export | 16452157
|
D016047 |
Zalcitabine |
[gp120 protein, Human immunodeficiency virus 1 co-treated with Zalcitabine] results in increased expression of ATP2B4 mRNA | affects cotreatment|increases expression | 18606552
|
D005419 |
Flavonoids |
Flavonoids results in decreased expression of ATP2B4 mRNA | decreases expression | 18035473
|
C514793 |
gp120 protein, Human immunodeficiency virus 1 |
[gp120 protein, Human immunodeficiency virus 1 co-treated with Zalcitabine] results in increased expression of ATP2B4 mRNA | affects cotreatment|increases expression | 18606552
|
C051890 |
irinotecan |
ATP2B4 protein results in decreased susceptibility to irinotecan | decreases response to substance | 16734730
|
D007657 |
Ketone Bodies |
Ketone Bodies results in decreased expression of ATP2B4 mRNA | decreases expression | 16807920
|
C008493 |
methylselenic acid |
methylselenic acid results in increased expression of ATP2B4 mRNA | increases expression | 18548127
|
D010656 |
Phenylephrine |
ATP2B4 protein results in increased susceptibility to Phenylephrine | increases response to substance | 12933703
|
D010710 |
Phosphates |
Phosphates affects the expression of ATP2B4 mRNA | affects expression | 16490722
|
C006253 |
pirinixic acid |
pirinixic acid results in increased expression of ATP2B4 mRNA | increases expression | 12832660
|
D011374 |
Progesterone |
Progesterone results in decreased expression of ATP2B4 mRNA | decreases expression | 18070364
|
D015237 |
Dinoprost |
ATP2B4 protein results in increased susceptibility to Dinoprost | increases response to substance | 12933703
|
D012643 |
Selenium |
Selenium results in increased expression of ATP2B4 mRNA | increases expression | 19244175
|
D014284 |
Triiodothyronine |
bisphenol A inhibits the reaction [Triiodothyronine results in increased expression of ATP2B4 mRNA] | decreases reaction|increases expression | 19228888
|
D014284 |
Triiodothyronine |
Triiodothyronine results in increased expression of ATP2B4 mRNA | increases expression | 19228888
|
C024746 |
tobacco tar |
tobacco tar results in decreased expression of ATP2B4 mRNA | decreases expression | 19559774
|
D014212 |
Tretinoin |
Tretinoin affects the expression of ATP2B4 mRNA | affects expression | 18230668
|
D014635 |
Valproic Acid |
Valproic Acid results in increased expression of ATP2B4 mRNA | increases expression | 19101580
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
3.36 | 8875741 |
MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
3.81 | 19490988 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.43 | 18287403 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
2.99 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
1.95 | 20127859 20464547 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
2.58 | 6695378 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
3.35 | 16434500 |
MESH:D018246 |
Adrenocortical Adenoma |
|
Arsenic |
5.08 | 17306315 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.51 | 15955085 |
MESH:D000550 |
Amblyopia |
|
Valproic Acid |
5.10 | 17688650 |
MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
3.47 | 17497229 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
3.94 | 19183758 |
MESH:D001145 |
Arrhythmias, Cardiac |
|
Phenylephrine |
4.00 | 17460149 |
MESH:D020261 |
Arsenic Poisoning |
|
Arsenic |
2.83 | 12569548 16835338 16251483 18414634 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
3.00 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
2.23 | 16292516 |
MESH:D001249 |
Asthma |
|
Tretinoin |
2.31 | 16456186 |
MESH:D050197 |
Atherosclerosis |
|
Arsenic |
3.17 | 12928151 19371607 |
MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
2.02 | 18985861 18177632 18558336 18396377 17507914 18940202 17688650 19460635 18316065 19232924 17157402 15238991 20603192 18775368 16609825 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
4.27 | 16935849 |
MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
3.01 | 20046352 17594078 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
8.57 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
8.57 | 16206674 16197459 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
3.32 | 8888407 |
MESH:D001862 |
Bone Resorption |
|
bisphenol A |
3.74 | 11985600 |
MESH:D001919 |
Bradycardia |
|
Phenylephrine |
4.41 | 15306635 |
MESH:D020201 |
Brain Hemorrhage, Traumatic |
|
Progesterone |
5.21 | 17868700 |
MESH:D001930 |
Brain Injuries |
|
Progesterone |
4.13 | 15665606 15380490 15845082 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
1.95 | 17474063 20146248 |
MESH:D001943 |
Breast Neoplasms |
|
bisphenol A |
1.95 | 17123778 |
MESH:D001943 |
Breast Neoplasms |
|
Progesterone |
1.95 | 17614352 16175315 15562024 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
1.95 | 16443354 16166294 16873071 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
4.46 | 16813970 |
MESH:D002280 |
Carcinoma, Basal Cell |
|
Arsenic |
3.52 | 15504454 17687452 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
5.03 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Arsenic |
3.14 | 17306315 16507464 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
3.14 | 1917145 |
MESH:D002278 |
Carcinoma in Situ |
|
bisphenol A |
4.86 | 17123778 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Arsenic |
7.33 | 18922899 15504454 17687452 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
7.33 | 20419170 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
7.33 | 16096774 16051514 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Arsenic |
3.96 | 18640142 |
MESH:D006332 |
Cardiomegaly |
|
Phenylephrine |
3.46 | 11754973 17287366 15728586 11179087 17124262 16170337 |
MESH:D009202 |
Cardiomyopathies |
|
Zalcitabine |
4.62 | 10591146 |
MESH:D002318 |
Cardiovascular Diseases |
|
Arsenic |
3.36 | 17938729 19152805 15738583 |
MESH:D002340 |
Carotid Artery Diseases |
|
Arsenic |
4.20 | 18022660 16973168 |
MESH:D002386 |
Cataract |
|
Tretinoin |
3.02 | 17460283 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Dinoprost |
7.56 | 16192471 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
tobacco tar |
7.56 | 19559774 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
4.46 | 16129372 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.66 | 20734317 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
2.73 | 19176532 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
5.03 | 16461808 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
2.61 | 9407595 |
MESH:D003092 |
Colitis |
|
Selenium |
9.06 | 17936198 |
MESH:D003092 |
Colitis |
|
Tretinoin |
9.06 | 17035595 |
MESH:D003110 |
Colonic Neoplasms |
|
irinotecan |
2.57 | 17725105 17287894 |
MESH:D015179 |
Colorectal Neoplasms |
|
irinotecan |
2.36 | 18259882 16391804 18509181 16303861 17159606 15273666 17454858 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
2.64 | 17551590 9224671 10589399 9211117 8800419 14991402 16925845 9664655 9125849 9142499 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
2.64 | 17688650 8888407 16575769 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.37 | 18249437 |
MESH:D003929 |
Diabetic Neuropathies |
|
Progesterone |
4.36 | 17187935 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Selenium |
3.88 | 15131321 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
3.88 | 19641884 1733752 |
MESH:D004362 |
Drug Toxicity |
|
Zalcitabine |
4.75 | 7515130 |
MESH:D004421 |
Dystonia |
|
Valproic Acid |
3.92 | 1851702 |
MESH:D004487 |
Edema |
|
pirinixic acid |
2.36 | 12083418 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
4.34 | 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Progesterone |
3.65 | 17692515 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
3.02 | 16569247 |
MESH:D004715 |
Endometriosis |
|
Progesterone |
3.65 | 16134523 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
4.02 | 3659116 17275665 |
MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
3.79 | 3922381 16628512 |
MESH:D004827 |
Epilepsy |
|
Valproic Acid |
2.87 | 20417680 18234410 |
MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
3.48 | 6426943 7562514 6254150 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
4.17 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
3.93 | 3659116 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
1.98 | 16530937 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
3.48 | 16938888 9664655 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
12.62 | 19236843 20131406 |
MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
12.62 | 14986274 19224547 |
MESH:D005234 |
Fatty Liver |
|
Zalcitabine |
12.62 | 18299183 |
MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
4.76 | 16575769 |
MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
4.00 | 18558336 8888407 |
MESH:D005334 |
Fever |
|
Dinoprost |
5.40 | 11852909 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
3.38 | 17994277 |
MESH:D005534 |
Foot Diseases |
|
Arsenic |
5.43 | 6392382 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
2.92 | 17312396 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
3.10 | 16096774 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
5.03 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
6.43 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
6.43 | 14991402 9664655 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
6.68 | 20558911 |
MESH:D006333 |
Heart Failure |
|
Selenium |
6.68 | 17162251 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
2.87 | 19176532 18467677 19772884 16221962 |
MESH:D015658 |
HIV Infections |
|
Zalcitabine |
4.27 | 17457083 |
MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
4.74 | 17688650 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
3.11 | 16870215 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.44 | 16778211 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.07 | 20558911 |
MESH:D017488 |
Hyperkeratosis, Epidermolytic |
|
Arsenic |
4.34 | 17050553 |
MESH:D006973 |
Hypertension |
|
Arsenic |
5.49 | 16076760 11953799 9931084 |
MESH:D006973 |
Hypertension |
|
Phenylephrine |
5.49 | 12717712 8949925 |
MESH:D006984 |
Hypertrophy |
|
Phenylephrine |
4.43 | 18502941 12791704 |
MESH:D006987 |
Hypesthesia |
|
Arsenic |
5.43 | 16093927 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
Progesterone |
4.27 | 15869954 |
MESH:D007249 |
Inflammation |
|
Flavonoids |
5.04 | 17296493 |
MESH:D007249 |
Inflammation |
|
Progesterone |
5.04 | 15869954 |
MESH:D007251 |
Influenza, Human |
|
Selenium |
4.07 | 16624496 |
MESH:D007333 |
Insulin Resistance |
|
bisphenol A |
7.03 | 16393666 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
7.03 | 16306350 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
3.64 | 17994277 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
3.78 | 17551590 15992940 |
MESH:D007642 |
Keratosis |
|
Arsenic |
4.86 | 12749816 16930632 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Selenium |
3.76 | 16518626 |
MESH:D007683 |
Kidney Tubular Necrosis, Acute |
|
Calcium |
4.92 | 16316344 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
2.71 | 17143497 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
3.58 | 16482212 16932348 19285840 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
3.80 | 16294345 19850784 17596541 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
3.80 | 16294345 17596541 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Arsenic |
7.47 | 17339181 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
7.47 | 17649720 16935935 17294898 12679006 16823087 16788101 19035177 17301526 17361223 16766008 19075265 17506722 9834237 16331271 16891316 19029980 17712046 15748426 17217047 19225113 17107899 17339181 16140955 19642359 17368321 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
3.21 | 9224671 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
2.30 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
2.30 | 16248980 18397230 |
MESH:D008107 |
Liver Diseases |
|
Arsenic |
2.51 | 11134558 |
MESH:D008113 |
Liver Neoplasms |
|
Arsenic |
7.15 | 16368122 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
7.15 | 21137059 20195826 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
7.15 | 15890375 20007298 16377806 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
4.13 | 17228818 |
MESH:D008175 |
Lung Neoplasms |
|
Arsenic |
2.50 | 19168569 17976673 17306315 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
2.50 | 6695378 17053015 20869020 18569708 20135361 18816296 18520028 20464547 20064080 |
MESH:D008223 |
Lymphoma |
|
Zalcitabine |
4.55 | 17941976 8764131 18798262 9205081 11980663 9488045 8840982 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Progesterone |
5.85 | 11408345 17203775 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Selenium |
5.85 | 15318939 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.73 | 17453147 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
1.93 | 16752155 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
4.29 | 16940565 |
MESH:D001523 |
Mental Disorders |
|
Phosphates |
4.88 | 12686366 |
MESH:D008654 |
Mesothelioma |
|
Selenium |
2.74 | 15107826 |
MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
3.10 | 18803445 18765137 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
3.09 | 16381670 |
MESH:D052016 |
Mucositis |
|
irinotecan |
4.88 | 17159606 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.38 | 16239165 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
3.91 | 8888407 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
7.15 | 17596541 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
7.15 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.09 | 19151258 |
MESH:D017202 |
Myocardial Ischemia |
|
Arsenic |
3.88 | 15371236 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
2.84 | 16411023 |
MESH:D009362 |
Neoplasm Metastasis |
|
irinotecan |
3.12 | 18259882 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
7.82 | 11141357 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
7.82 | 17405874 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
7.82 | 16594593 16946489 |
MESH:D009374 |
Neoplasms, Experimental |
|
Zalcitabine |
4.97 | 9205081 9488045 8764131 |
MESH:D009421 |
Nervous System Malformations |
|
bisphenol A |
9.37 | 11399458 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
9.37 | 9125849 |
MESH:D009437 |
Neuralgia |
|
Zalcitabine |
6.19 | 17292584 |
MESH:D009436 |
Neural Tube Defects |
|
Arsenic |
11.71 | 16620997 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
11.71 | 9142499 |
MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
11.71 | 8888407 16359493 |
MESH:D009447 |
Neuroblastoma |
|
irinotecan |
3.41 | 8761367 |
MESH:D017599 |
Neuroectodermal Tumors |
|
irinotecan |
4.60 | 8761367 |
MESH:D020078 |
Neurogenic Inflammation |
|
Arsenic |
4.25 | 17056641 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.78 | 20558911 |
MESH:D010024 |
Osteoporosis |
|
Calcium |
3.70 | 17882678 |
MESH:D010049 |
Ovarian Diseases |
|
bisphenol A |
4.86 | 11985600 |
MESH:D010051 |
Ovarian Neoplasms |
|
Arsenic |
7.72 | 17306315 |
MESH:D010051 |
Ovarian Neoplasms |
|
Progesterone |
7.72 | 17393432 16525653 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
7.72 | 16936753 |
MESH:D010146 |
Pain |
|
Tretinoin |
2.80 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
2.42 | 15976015 |
MESH:D010523 |
Peripheral Nervous System Diseases |
|
Arsenic |
16.19 | 16093927 |
MESH:D010523 |
Peripheral Nervous System Diseases |
|
gp120 protein, Human immunodeficiency virus 1 |
16.19 | 18606552 |
MESH:D010523 |
Peripheral Nervous System Diseases |
|
Zalcitabine |
16.19 | 18606552 |
MESH:D016491 |
Peripheral Vascular Diseases |
|
Arsenic |
4.86 | 16905509 6392382 15371236 |
MESH:D010954 |
Plasmacytoma |
|
Selenium |
4.76 | 15087411 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
bisphenol A |
9.31 | 10548101 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
9.31 | 20603192 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
bisphenol A |
4.09 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
Arsenic |
2.14 | 16140617 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
2.14 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
bisphenol A |
2.14 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
methylselenic acid |
2.14 | 16205645 |
MESH:D011507 |
Proteinuria |
|
Arsenic |
8.86 | 21343184 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
8.86 | 16636307 |
MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
4.41 | 12752131 11422049 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
4.66 | 16723453 |
MESH:D011629 |
Puberty, Precocious |
|
bisphenol A |
4.65 | 10548101 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.32 | 19058328 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
10.45 | 16283617 16116481 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
10.45 | 19155313 |
MESH:D012468 |
Salivary Gland Neoplasms |
|
Progesterone |
2.81 | 18045962 |
MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
2.05 | 15737665 19110320 |
MESH:D012640 |
Seizures |
|
Valproic Acid |
2.65 | 3137016 16876388 1511512 15475178 11044598 11738929 14763951 17978042 |
MESH:D012852 |
Sinusitis |
|
Phenylephrine |
4.57 | 7327846 |
MESH:D012871 |
Skin Diseases |
|
Arsenic |
2.71 | 18709164 17938729 17050553 17548696 15952646 17453740 19834688 16702368 6392382 16353154 16759981 |
MESH:D012878 |
Skin Neoplasms |
|
Arsenic |
9.16 | 17976673 17029826 16251483 17050553 15504454 19538983 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
9.16 | 19755658 10029692 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
9.16 | 16467112 |
MESH:D013119 |
Spinal Cord Injuries |
|
Progesterone |
4.15 | 16503802 15862959 |
MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
3.68 | 19490988 |
MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
4.41 | 12833885 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
3.34 | 20155912 2093021 |
MESH:D013274 |
Stomach Neoplasms |
|
irinotecan |
3.34 | 15723263 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
3.34 | 17261132 |
MESH:D019966 |
Substance-Related Disorders |
|
bisphenol A |
3.85 | 16045194 16684133 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
2.93 | 16026305 17045167 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
3.67 | 16051514 |
MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
5.10 | 17262798 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
3.15 | 16040207 |
MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
4.39 | 3119515 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Arsenic |
5.00 | 19429237 17306315 18640142 11144890 15987713 19322015 17976673 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
5.00 | 17053015 |
MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
4.51 | 8888407 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
3.56 | 16129372 |
MESH:D014591 |
Uterine Diseases |
|
bisphenol A |
4.88 | 14652134 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
4.48 | 16752155 |
MESH:D014652 |
Vascular Diseases |
|
Arsenic |
4.60 | 17056641 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
3.93 | 16761959 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
3.85 | 16287080 |